Does agricultural use of azole fungicides contribute to resistance in the human pathogen Aspergillus fumigatus?

Pest Management Science

Volumn 73, Issue 10, 2017, Pages 1987-1993

  Hollomon, Derek ^a  

^a Orchard House   (United Kingdom)

Author keywords

aspergillosis; Aspergillus fumigatus; azoles; CYP51; DMI fungicides; drug resistance; itraconazole; paralogue; sterol 14 demethylase

Indexed keywords

DISEASE CONTROL; DRUG; DRUG RESISTANCE; FUNGAL DISEASE; FUNGICIDE; FUNGUS; PATHOGEN; PESTICIDE RESISTANCE; PROTEIN;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS SP.; FUNGI;

FUNGICIDE; PYRROLE DERIVATIVE;

ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CROP PROTECTION; DRUG EFFECT; GENETIC SELECTION; GENETICS; HUMAN; MICROBIOLOGY;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AZOLES; CROP PROTECTION; DRUG RESISTANCE, FUNGAL; FUNGICIDES, INDUSTRIAL; HUMANS; SELECTION, GENETIC;

EID: 85028535831     PISSN: 1526498X     EISSN: 15264998     Source Type: Journal    
DOI: 10.1002/ps.4607     Document Type: Article

References (50)

1. Largé JP, Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12:310–355 (1999).
2. Fletcher JT and Wolfe MS, Insensitivity of Erysiphe graminis f.sp. hordei to triadimenol, triadimefon and other fungicides. Proc Br Crop Prot Conf Pests Dis 2:633–640 (1981).
3. Cowen LED, Sanglard D, Calabrese C, Sirjusingh C, Anderson JB and Kohn LM, Evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 182:1515–1522 (2000).
4. Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA et al., Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agent Chemother 41:1364–1368 (1997).
5. Snelders E, van der Lee HAL, Kuijpers J, Rijs AJMM, Varga J, Samson RA et al., Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5:e219 (2008).
6. Verweij PE, Kema GHJ, Zwaan B and Melchers WJG, Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mould Aspergillus fumigatus. Pest Manag Sci 69:165–170 (2012).
7. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC et al., Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15:1068–1076 (2009).
8. Snelders E, Huis in't Veld RA, Rijs AJ, Kema GH, Melchers WJ and Verweij PE, Possible environmental origin of resistance in Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol 75:4053–4057 (2009).
9. Snelders E, Camps SMT, Karawajczyk A, Schaftenaar G, Kema GHJ, van der Lee HA et al., Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One 7:e31801 (2012).
10. Chowdhary A, Kathuria S, Xu J and Mels JF, Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathogens 9:e100363 (2013).
11. Serfling A, Wohlrab J and Deising HB, Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. Antimicrob Agent Chemother 51:1672–1676 (2007).
12. Bowyer P and Denning DW, Environmental fungicides and triazole resistance in Aspergillus. Pest Manag Sci 70:173–178 (2014).
13. Gisi U, Assessment of selection and resistance risk for demethylation inhibitor fungicides in Aspergillus fumigatus in agriculture and medicine: a critical review. Pest Manag Sci 70:352–364 (2014).
14. Verweij PE, Chowdhary A, Melchers WJG and Meis J, Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis 62:362–368 (2016).
15. Ribas e Ribas AD, Spolti P, Del Ponte EM, Donato KZ, Schrekker H and Fuentefria AM, Is the emergence of fungal resistance to medical azoles related to their use in agroecosystems? A mini review. Brazilian J Microbiol 47:793–799 (2016).
16. Bromilow RH, Evans A and Nichols PH, Factors affecting degradation rates of five triazole fungicides in two field types: 2. Field studies. Pestic Sci 55:1135–1142 (1999).
17. Klich MA, Biogeography of Aspergillus species in soils and litter. Mycologia 94:21–27 (2002).
18. Domsch KH, Gams W and Anderson T-H, Compendium of Soil Fungi, Vol. 1. Academic Press, London (1980).
19. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard M38A. National Committee for Clinical Laboratory Standards, Wayne, PA (2002).
20. Meneau I and Sanglard D, Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates. Med Mycol 43(Suppl 1):S307–S311 (2005).
21. Faria-Ramos I, Farinah S, Neves-Maia J, Tavares PR, Miranda IM, Estevinho LM et al., Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole. BMC Microbiol 14:155 (2014).
22. Nascimento AM, Goldman GH, Park S, Marras SAE, Delmas G, Oza U et al., Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agent Chemother 47:1719–1726 (2003).
23. Slaven JW, Anderson MJ, Sanglard D, Dixon GK, Bille J, Roberts IS et al., Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol 36:199–206 (2002).
24. Buied A, Moore CB, Denning DW and Bowyer P, High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates. J Antimicrob Chemother 68:512–514 (2013).
25. Fraczek MG, Bromley M, Bieud A, Moore CB, Rajendran R, Rautemaa R et al., The cdr1B efflux transporter with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 68:1486–1496 (2013).
26. Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ and Balajee SA, Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agent Chemother 55:4465–4468 (2011).
27. 34L98H alterations in Aspergillus fumigatus isolates from azole-naïve patients in Denmark despite negative findings in the environment. Antmicrob Agent Chemother 58:5096–5101 (2014).
28. Ziogas BN and Malandrakis AA, Sterol biosynthesis inhibitors: C14 demethylation (DMIs), in Fungicide Resistance in Plant Pathogens: Principles and a Guide to Practical Management, ed. by Ishii H and Hollomon DW. Springer, Tokyo, pp. 199–216 (2015).
29. Fan J, Urban M, Parker JE, Brewer HC, Kelly SL, Hammond-Kosack KE et al., Characterization of the sterol 14α-demethylases of Fusarium graminearum identifies a novel genus-specific CYP51 function. New Phytol 198:821–835 (2013).
30. Warrilow AGS, Melo N, Martel CM, Parker JE, Nes WD, Kelly SL et al., Expression, purification, and characterization of Aspergillosis fumigatus sterol 14α-demethylase (CYP51) isozymes A and B. Antimicrob Agent Chemother 54:4225–4234 (2010).
31. Mellado E, Garcia-Effron G, Buitrago MJ, Alcazar-Fuoli L, Cuenca-Estrella M and Rodriguez-Tudela JL, Targeted gene disruption of the 14α sterol demethylase (cyp51A) in Aspergillosis fumigatus and its role in drug susceptibility. Antimicrob Agent Chemother 49:2536–2538 (2005).
32. Cools HJ, Hawkins NJ and Fraaije BA, Constraints on the evolution of azole resistance in plant pathogenic fungi. Plant Pathol 62(Suppl 1):36–42 (2013).
33. Hawkins NJ, Cools HJ, Sierotzki H, Shaw MW, Knogge W, Kelly SL et al., Paralogue re-emergence: a novel, historically contingent mechanism in the evolution of antimicrobial resistance. Mol Biol Evol 33:1793–1802 (2014).
34. Mair WJ, Deng W, Mullins JGL, West S, Wang P, Besharat N et al., Demethylase inhibitor fungicide resistance in Pyrenophora teres f. sp. teres associated with target site modification and inducible overexpression of Cyp51. Front Microbiol 7:1279 (2016).
35. Martel CM, Parker JE, Warrilow AGS, Rolley NJ, Kelly SL and Kelly DE, Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) deoxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isozymes CYP51A and CYP51B. Antimicrob Agent Chemother 54:4920–4923 (2010).
36. Fraaije BA, Cools HJ, Kim S-H, Motteram J, Clark WS and Lucas JA, A novel substitution I381V in the sterol 14-α-demethylase (CYP51) of Mycosphaerella graminicola is differentially selected by azole fungicides. Mol. Plant Pathol 8:245–253 (2007).
37. Tyndall JDA, Sabherwal M, Sagatove AA, Keniya MV, Negroni J, Wilson RK et al., Structural and functional elucidation of yeast lanosterol 14α-demethylase in complex with agricultural antifungals. PloS ONE 11:e0167485 (2016).
38. de Valk HA, Meis JFGM, Curfs IM, Muehlethaler K, Mouton JW and Klaassen CHW, Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J Clin Microbiol 43:4112–4120 (2005).
39. Klaasen CHW, Gibbons JG, Federova ND, Meis JF and Rokas A, Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus. J Mol Ecol 21:57–70 (2012).
40. Hargrove TY, Wawrzak Z, Lamb DC, Guengerich FP and Lepeshevva GI, Structure-functional characterization of cytochrome P450 sterol 14α-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for development of antifungal drugs. J Biol Chem 290:23916–23934 (2015).
41. Mullins JGL, Parker JE, Cools HJ, Togawa RC, Lucas JA, Fraaije BA et al., Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola. PLoS ONE 6:e20973 (2011).
42. Ren J, Jin X, Zhang Q, Zheng Y, Lin D and Yu Y, Fungicides induced triazole-resistance in Aspergillus fumigatus associated with mutations of TR46/Y121F/T289A and its appearance in agricultural fields. J Hazard Mater 326:54–60 (2017).
43. Dannaoui E, Persat F, Monier M-F, Borel E, Piens M-A and Picot S, In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J Antimicrob Chemother 44:553–555 (1999).
44. Hollomon DW and Ishii H, Monitoring resistance using molecular methods, in Fungicide Resistance in Plant Pathogens: Principles and a Guide to Practical Management, ed. by Ishii H and Hollomon DW. Springer, Tokyo, pp. 295–309 (2015).
45. Brent KJ and Hollomon DW, Fungicide Resistance: The Assessment of Risk, FRAC Monograph 2, second revised edition. Crop Life International, Brussels (2007).
46. O'Gorman CM, Fuller HT and Dyer PS, Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus. Nature 457:471–474 (2009).
47. Rydholm C, Szalacs G and Lutzoni F, Low genetic variation and no detectable population structure in Aspergillus fumigatus compared to closely related Neosartorya species. Eukaryotic Cell 5:650–657 (2006).
48. Diaz-Guerra TM, Mellado E, Cuensa-Estrella M and Rodriguez-Tudela JL, A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agent Chemother 47:1120–1124 (2003).
49. Chamilos G and Kontoyiannis DP, Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updates 8:344–358 (2005).
50. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Melchers WJG, Verweij PE, Cuenca-Estrella M et al., A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungal involves a combination of cyp51A alterations. Antmicrob Agent Chemother 51:1897–1904 (2007).